Halozyme Therapeutics, Inc. (HALO)

71.21 -0.61 (-0.85%) USD  |  NASDAQ  |  Jan 16, 16:00
71.20 -0.01 (-0.01%) After-Hours: 20:00
More

Halozyme Therapeutics Total Long Term Liabilities (Quarterly)

Total Long Term Liabilities (Quarterly) Chart

View Total Long Term Liabilities (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Liabilities (Quarterly) Range, Past 5 Years

View Total Long Term Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Liabilities (Quarterly) Benchmarks

View Total Long Term Liabilities (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. --
Stryker Corp. --
Skye Bioscience, Inc. --